CBPO News and Press, China Biologic Products Holdings Inc. From 11/23/20

Merger activity increased last week with four new deals announced. The acquisition of HD Supply Holdings by The Home Depot. The acquisition of Foundation Building Materials by American Securities. For further details see: Merger Arbitrage Mondays - Home Depot B...

China Biologic Products (CBPO) inked a definitive Agreement and Plan of Merger with CBPO Holdings and CBPO Group, wholly owned subsidiary of Parent; in a transaction implying an equity value of the company of ~$4.76B.Post the merger agreement, CBPO Group will merge with and into the...

China Biologic Products to Report Third Quarter 2020 Financial Results PR Newswire BEIJING, Nov. 13, 2020 BEIJING , Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integr...

Image source: The Motley Fool. China Biologic Products Inc   (NASDAQ: CBPO) Q2 2020 Earnings Call Aug 18, 2020 , 7:30 a.m. ET Operator Continue reading

China Biologic Products Holdings, Inc. (CBPO) Q2 2020 Results Earnings Conference Call August 18, 2020, 07:30 AM ET Company Participants Philip Lisio - The Foote Group Joseph Chow - Chairman and Chief Executive Officer Ming Yin - Senior Vice President Ming Yang - Chief Financia...

China Biologic Products ( CBPO -1.9% ) Q2 reports total sales of $111.1M (-18.1% Y/Y). More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Read more ...

China Biologic Products (NASDAQ: CBPO ) : Q2 Non-GAAP EPS of $1.11 misses by $0.17 ; GAAP EPS of $0.91. More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BEIJING , Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its unaudited financial results for the second quarter of 2020. ...

BEIJING , Aug. 10, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its second quarter 2020 fin...

BEIJING , June 29, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today declared that the Company disagrees with the notice delivered by Xinjiang D...